For how we live.
The final Q&A guidance explains how FDA will use the power to order recalls of cosmetics it gained under the 2022 Modernization of Cosmetics Regulation Act, adopting the December 2025 draft with no substantive changes.
A new draft Chapter 12 explains how food manufacturers should control chemical hazards under the FSMA preventive-controls rule. It joins a multichapter guidance built since 2016; comments close 21 January 2027.
An interim final rule lets HHS freeze federal-marketplace registration for agents and brokers without a current plan-year agreement. CMS imposed the pause immediately; it runs until 1 February 2027.
A dormant breach-notification rule became an enforcement tool in 2023, when the FTC fined GoodRx and BetterHelp for sharing users' health data with ad platforms. A 2024 rule change locked apps into its reach.
Rings and watches sold online promise needle-free glucose readings. The FDA says do not use any of them, and even research-grade non-invasive sensors miss the mark by about a fifth.
A review of 23 women's health apps found 87% shared user data with outside firms. The main US rule that covers them orders breach disclosure — it does not stop the sharing.
An audit of 17 manufacturers' privacy policies found transparency the weakest area, with wide variation between brands. The data these devices generate largely falls outside HIPAA and GDPR's clinical protections.
It is a medical-device biocompatibility standard, now built largely on lab-grown skin rather than animals. It measures whether a material irritates. It says nothing about whether a product works.
FTC staff guidance is explicit: an honest testimonial is not evidence. The advertiser still needs competent and reliable science for the claim the testimonial implies.
Most textiles sold as bamboo are rayon made from bamboo, and US regulators have said so for over a decade. In 2022 the FTC put a $5.5 million price on the difference.